[HTML][HTML] Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of …

…, A Nebykova, SA Kerridge, J Hill, H Thomaides-Brears… - The Lancet, 2017 - thelancet.com
Background Salmonella enterica serovar Typhi (S Typhi) is responsible for an estimated 20
million infections and 200 000 deaths each year in resource poor regions of the world. …

[HTML][HTML] Incidence of complications from percutaneous biopsy in chronic liver disease: a systematic review and meta-analysis

HB Thomaides-Brears, N Alkhouri, D Allende… - Digestive Diseases and …, 2022 - Springer
… The same conclusion was drawn when the few transjugular and endoscopic biopsy studies
identified during this systematic review were included (Thomaides-Brears unpublished). In …

Multi-organ impairment and long COVID: a 1-year prospective, longitudinal cohort study

…, H Thomaides-Brears… - Journal of the Royal …, 2023 - journals.sagepub.com
Objectives To determine the prevalence of organ impairment in long COVID patients at 6
and 12 months after initial symptoms and to explore links to clinical presentation. Design …

Antibacterial alkoxybenzamide inhibitors of the essential bacterial cell division protein FtsZ

…, C Rockley, V Rose, HB Thomaides-Brears… - Bioorganic & medicinal …, 2009 - Elsevier
Antibacterial alkoxybenzamide inhibitors of the essential bacterial cell division protein FtsZ -
ScienceDirect Skip to main contentSkip to article Elsevier logo Journals & Books Search …

Cardiac abnormalities in Long COVID 1-year post-SARS-CoV-2 infection

…, A Borlotti, D Monteiro, H Thomaides-Brears… - Open …, 2023 - openheart.bmj.com
Background Long COVID is associated with multiple symptoms and impairment in multiple
organs. Cross-sectional studies have reported cardiac impairment to varying degrees by …

Evaluation of the Clinical and Microbiological Response to Salmonella Paratyphi A Infection in the First Paratyphoid Human Challenge Model

…, C Jones, HB Thomaides-Brears… - Clinical Infectious …, 2017 - academic.oup.com
Background. To expedite the evaluation of vaccines against paratyphoid fever, we aimed to
develop the first human challenge model of Salmonella enterica serovar Paratyphi A …

[HTML][HTML] Liver disease is a significant risk factor for cardiovascular outcomes–A UK Biobank study

…, R Banerjee, H Thomaides-Brears… - Journal of …, 2023 - Elsevier
Background & Aims Chronic liver disease (CLD) is associated with increased cardiovascular
disease (CVD) risk. We investigated whether early signs of liver disease (measured by iron-…

[HTML][HTML] Investigation of the role of typhoid toxin in acute typhoid fever in a human challenge model

…, C Jones, D Campbell, C Black, H Thomaides-Brears… - Nature medicine, 2019 - nature.com
Salmonella Typhi is a human host-restricted pathogen that is responsible for typhoid fever
in approximately 10.9 million people annually 1 . The typhoid toxin is postulated to have a …

DNA gyrase (GyrB)/topoisomerase IV (ParE) inhibitors: synthesis and antibacterial activity

…, C Smee, HB Thomaides-Brears… - Bioorganic & medicinal …, 2009 - Elsevier
The synthesis and antibacterial activities of three chemotypes of DNA supercoiling inhibitors
based on imidazolo[1,2-a]pyridine and [1,2,4]triazolo[1,5-a]pyridine scaffolds that target the …

[HTML][HTML] Multiparametric MR mapping in clinical decision-making for diffuse liver disease

HB Thomaides-Brears, R Lepe, R Banerjee… - Abdominal …, 2020 - Springer
Accurate diagnosis, monitoring and treatment decisions in patients with chronic liver disease
currently rely on biopsy as the diagnostic gold standard, and this has constrained early …